Detalhe da pesquisa
1.
Assessing the clinical utility of genetic risk scores for targeted cancer screening.
J Transl Med
; 19(1): 41, 2021 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33482857
2.
Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk score.
Prostate
; 2018 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29923209
3.
Germline mutations in DNA repair genes are associated with bladder cancer risk and unfavourable prognosis.
BJU Int
; 122(5): 808-813, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29727914
4.
A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).
Prostate
; 77(11): 1213-1220, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28656603
5.
Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial.
Prostate
; 77(11): 1179-1186, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28670847
6.
Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in China.
Prostate
; 77(11): 1221-1229, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28664580
7.
A multiparametric approach to improve upon existing prostate cancer screening and biopsy recommendations.
Curr Opin Urol
; 27(5): 475-480, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28614085
8.
A review of biosimilars for rheumatoid arthritis.
Curr Opin Pharmacol
; 64: 102234, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35552095
9.
Personalized prostate cancer care: from screening to treatment.
Asian J Androl
; 18(4): 505-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27184548
10.
Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.
Asian J Androl
; 18(4): 520-4, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27080480